besides , the serum molybdenum level ( mean +/- s.d . ) was observed to be definitely increased in patients with hbsag-positive chronic active hepatitis ( 0.97 +/- 0.49 ng/ml ) , hbsag-positive liver cirrhosis ( 1.01 +/- 0.50 ) , alcoholic liver disease ( 1.32 +/- 0.56 ) , liver metastases ( 1.40 +/-0.39 ) , gallstones ( 1.28 +/- 0.38 ) , tumors of the gallbladder or extrahepatic bile ducts ( 1.64 +/- 0.44 ) , and carcinoma of the head of the pancreas ( 1.61 +/- 0.91 ) .
C0494165
liver metastases
C0206187
extrahepatic bile ducts